Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis. Chang JW, Huang X, Jiang W, Lun L, et al. J Am Acad Dermatol 2025 Apr 15:S0190-9622(25)00621.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang JW, Huang X, Jiang W, Lun L, et al. Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis. J Am Acad Dermatol 2025 Apr 15:S0190-9622(25)00621.
PMID: 40246083